GB0128638D0 - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
GB0128638D0
GB0128638D0 GB0128638A GB0128638A GB0128638D0 GB 0128638 D0 GB0128638 D0 GB 0128638D0 GB 0128638 A GB0128638 A GB 0128638A GB 0128638 A GB0128638 A GB 0128638A GB 0128638 D0 GB0128638 D0 GB 0128638D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
therapeutic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0128638A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICE Biologics Ltd
Original Assignee
ICE Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICE Biologics Ltd filed Critical ICE Biologics Ltd
Priority to GB0128638A priority Critical patent/GB0128638D0/en
Publication of GB0128638D0 publication Critical patent/GB0128638D0/en
Priority to KR10-2004-7000049A priority patent/KR20040030786A/en
Priority to IL15968202A priority patent/IL159682A0/en
Priority to DE60237447T priority patent/DE60237447D1/en
Priority to EA200400134A priority patent/EA013517B1/en
Priority to PL367828A priority patent/PL216741B1/en
Priority to BR0210772-4A priority patent/BR0210772A/en
Priority to NZ530393A priority patent/NZ530393A/en
Priority to US10/482,399 priority patent/US20100291102A1/en
Priority to CA2452986A priority patent/CA2452986C/en
Priority to HU0401392A priority patent/HU228957B1/en
Priority to CNB028171705A priority patent/CN100423776C/en
Priority to EP02745565A priority patent/EP1404367B1/en
Priority to PCT/GB2002/003037 priority patent/WO2003004049A2/en
Priority to JP2003510059A priority patent/JP5014562B2/en
Priority to AT02745565T priority patent/ATE478681T1/en
Priority to DK02745565.8T priority patent/DK1404367T3/en
Priority to KR1020097007314A priority patent/KR100938590B1/en
Priority to MXPA04000147A priority patent/MXPA04000147A/en
Priority to AU2002317285A priority patent/AU2002317285B2/en
Priority to HK04107658.4A priority patent/HK1064936A1/en
Priority to JP2009091136A priority patent/JP5128539B2/en
Priority to US13/315,830 priority patent/US20120100156A1/en
Priority to IL221708A priority patent/IL221708A/en
Priority to US13/763,435 priority patent/US20130230600A1/en
Priority to US14/793,716 priority patent/US20160002320A1/en
Ceased legal-status Critical Current

Links

GB0128638A 2001-07-02 2001-11-29 Therapeutic agent Ceased GB0128638D0 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
GB0128638A GB0128638D0 (en) 2001-11-29 2001-11-29 Therapeutic agent
AU2002317285A AU2002317285B2 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-HIV goat serum as a therapeutic agent
EP02745565A EP1404367B1 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent
JP2003510059A JP5014562B2 (en) 2001-07-02 2002-07-02 Remedy
DE60237447T DE60237447D1 (en) 2001-07-02 2002-07-02 USE OF POLYCLONAL ANTI-HIV GOUGENES AS A THERAPEUTIC AGENT
EA200400134A EA013517B1 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent for the preparation of a medicament
PL367828A PL216741B1 (en) 2001-07-02 2002-07-02 Therapeutic agent
BR0210772-4A BR0210772A (en) 2001-07-02 2002-07-02 Uses of an anti-hla antibody, and a goat serum composition
NZ530393A NZ530393A (en) 2001-07-02 2002-07-02 High titre antibodies to FAS (CD95/Apo-1) might lead to the inhibition of toxic chemokines, which are thought to be involved in MS induced disability
US10/482,399 US20100291102A1 (en) 2001-07-02 2002-07-02 Therapeutic Agent
CA2452986A CA2452986C (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent
HU0401392A HU228957B1 (en) 2001-07-02 2002-07-02 Use anti-hla-antibody for production of pharmaceutical compotisions for the treatment of diseases involving prolierative immune response
CNB028171705A CN100423776C (en) 2001-07-02 2002-07-02 Therapeutic agent
KR10-2004-7000049A KR20040030786A (en) 2001-07-02 2002-07-02 Therapeutic agent
PCT/GB2002/003037 WO2003004049A2 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent
IL15968202A IL159682A0 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent
AT02745565T ATE478681T1 (en) 2001-07-02 2002-07-02 USE OF POLYCLONAL ANTI-HIV GOAT SERA AS A THERAPEUTIC AGENT
DK02745565.8T DK1404367T3 (en) 2001-07-02 2002-07-02 Use of polyclonal anti-HIV goat serum as a therapeutic agent
KR1020097007314A KR100938590B1 (en) 2001-07-02 2002-07-02 Use of Polyclonal Anti-HIV Goat Serum as a Therapeutic Agent
MXPA04000147A MXPA04000147A (en) 2001-07-02 2002-07-02 Use of polyclonal anti-hiv goat serum as a therapeutic agent.
HK04107658.4A HK1064936A1 (en) 2001-07-02 2004-10-06 Use of polyclonal anti-hiv goat serum as a therapeutic agent
JP2009091136A JP5128539B2 (en) 2001-07-02 2009-04-03 Remedy
US13/315,830 US20120100156A1 (en) 2001-07-02 2011-12-09 Therapeutic Agent
IL221708A IL221708A (en) 2001-07-02 2012-08-30 Goat anti-hla class ii antibody for treatment of cancer
US13/763,435 US20130230600A1 (en) 2001-07-02 2013-02-08 Therapeutic agent
US14/793,716 US20160002320A1 (en) 2001-07-02 2015-07-07 Therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0128638A GB0128638D0 (en) 2001-11-29 2001-11-29 Therapeutic agent

Publications (1)

Publication Number Publication Date
GB0128638D0 true GB0128638D0 (en) 2002-01-23

Family

ID=9926705

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0128638A Ceased GB0128638D0 (en) 2001-07-02 2001-11-29 Therapeutic agent

Country Status (1)

Country Link
GB (1) GB0128638D0 (en)

Similar Documents

Publication Publication Date Title
GB0119152D0 (en) Therapeutic agents
GB0113841D0 (en) Therapeutic agents
GB0128885D0 (en) Therapeutic agents
GB0120347D0 (en) Therapeutic agents
GB0117060D0 (en) Therapeutic agents
GB0114867D0 (en) Therapeutic agents
GB0108930D0 (en) Therapeutic agents
GB0113842D0 (en) Therapeutic agents
GB0113839D0 (en) Therapeutic agents
GB0111191D0 (en) Therapeutic agents
GB0113843D0 (en) Therapeutic agents
GB0030067D0 (en) Therapeutic agent
GB0119370D0 (en) Therapeutic agent
GB0119803D0 (en) Therapeutic agents
GB0108982D0 (en) Therapeutic agents
GB0120345D0 (en) Therapeutic agents
GB0119828D0 (en) Therapeutic agents
GB0128122D0 (en) Therapeutic use
GB0108973D0 (en) Therapeutic agents
GB0125210D0 (en) Therapeutic agent
GB0108589D0 (en) Therapeutic agent
GB0116151D0 (en) Therapeutic agent
GB0128638D0 (en) Therapeutic agent
GB0126880D0 (en) Therapeutic agents
GB0107134D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)